Yoshiaki Hattori
Yoshiaki Hattori works in Research and Development Planning at the CoreMed Corporation in Osaka, Japan.
JournalCan the Japanese phase I study be waived?
New guidance: ‘Basic principles for conducting phase I studies in Japanese prior to initiating multi-regional clinical trials including Japan for drugs in which early clinical development is preceding outside Japan,’ issued in December 2023